— Know what they know.
Not Investment Advice

ANGO NASDAQ

AngioDynamics, Inc.
1W: +8.4% 1M: +7.5% 3M: +6.6% YTD: -5.7% 1Y: +25.8% 3Y: +26.8% 5Y: -47.9%
$11.92
-0.04 (-0.33%)
 
Weekly Expected Move ±4.1%
$10 $10 $11 $11 $12
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 59 · $492.5M mcap · 37M float · 1.07% daily turnover · Short 30% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.3 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: -18.0%  ·  5Y Avg: -36.9%
Cost Advantage
30
Intangibles
31
Switching Cost
12
Network Effect
55
Scale ★
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ANGO has No discernible competitive edge (36.3/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. Negative ROIC of -18.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$18
Avg Target
$18
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$17.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-10-03 Canaccord Genuity $17 $18 +1 +53.3% $11.74
2025-07-16 Canaccord Genuity John Young $12 $17 +5 +95.0% $8.72
2024-10-04 Canaccord Genuity William Plovanic Initiated $12 +96.7% $6.10
2024-09-20 H.C. Wainwright Yi Chen Initiated $14 +81.8% $7.70
2024-04-05 Oppenheimer Steven Lichtman Initiated $12 +87.5% $6.40
2023-01-06 Raymond James $27 $22 -5 +42.1% $15.48
2022-07-13 Raymond James Initiated $27 +34.9% $20.02

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ANGO receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 C- D+
2026-04-02 D+ C-
2026-01-06 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

45 Grade D
Profitability
16
Balance Sheet
0
Earnings Quality
54
Growth
73
Value
38
Momentum
69
Safety
50
Cash Flow
41
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ANGO scores highest in Growth (73/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.19
Grey Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.97
Unlikely Manipulator
Ohlson O-Score
-7.36
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB+
Score: 47.4/100
Trend: Improving
Earnings Quality
OCF/NI: 0.20x
Accruals: -7.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ANGO scores 2.19, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ANGO scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ANGO's score of -2.97 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ANGO's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ANGO receives an estimated rating of BB+ (score: 47.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-15.80x
PEG
-0.62x
P/S
1.57x
P/B
2.86x
P/FCF
-55.03x
P/OCF
EV/EBITDA
-135.40x
EV/Revenue
1.49x
EV/EBIT
-16.72x
EV/FCF
-49.04x
Earnings Yield
-5.40%
FCF Yield
-1.82%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ANGO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.013
EBT / EBIT
×
EBIT Margin
-0.089
EBIT / Rev
×
Asset Turnover
1.028
Rev / Assets
×
Equity Multiplier
1.539
Assets / Equity
=
ROE
-14.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ANGO's ROE of -14.3% is driven by Asset Turnover (1.028), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$11.92
Median 1Y
$9.49
5th Pctile
$4.31
95th Pctile
$20.91
Ann. Volatility
53.0%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
James C. Clemmer
President, CEO
$803,027 $2,628,871 $5,494,285
Stephen A. Trowbridge
EVP, CFO
$455,847 $934,085 $2,161,797
Laura Piccinini SVP
& GM, Cardiovascular and International
$410,056 $414,834 $1,369,426
Lawrence T. Weiss
SVP & Chief Legal Officer
$206,731 $376,257 $1,170,067
Warren Nighan SVP
& GM, Global Supply Chain, Quality and Regulatory Affairs
$401,309 $337,186 $1,165,146

CEO Pay Ratio

26:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,494,285
Avg Employee Cost (SGA/emp): $215,151
Employees: 675

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
675
-9.8% YoY
Revenue / Employee
$433,330
Rev: $292,498,000
Profit / Employee
$-50,360
NI: $-33,993,000
SGA / Employee
$215,151
Avg labor cost proxy
R&D / Employee
$38,847
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -31.6% -7.0% -7.7% -8.6% -8.9% -6.1% -7.5% -7.6% -8.6% -13.1% 1.6% -3.5% -47.9% -63.1% -83.2% -77.0% -14.2% -17.5% -16.5% -14.3% -14.26%
ROA -23.6% -5.5% -5.9% -6.6% -6.9% -4.8% -5.8% -5.9% -6.7% -9.7% 1.2% -2.6% -35.4% -43.4% -57.2% -52.9% -9.7% -11.4% -10.7% -9.3% -9.27%
ROIC -30.4% -6.8% -7.3% -8.1% -8.4% -5.2% -6.2% -6.1% -6.8% -10.2% -0.6% -1.6% -39.4% -1.1% -1.4% -1.4% -28.6% -24.8% -23.3% -18.0% -17.97%
ROCE -31.3% -7.0% -7.7% -8.5% -8.8% -6.1% -7.2% -6.1% -6.0% -9.6% -8.8% -9.5% -10.9% -14.9% -14.5% -13.8% -11.6% -11.8% -12.8% -13.4% -13.42%
Gross Margin 54.1% 55.1% 52.1% 51.8% 52.2% 53.4% 51.9% 52.8% 50.2% 50.9% 50.9% 50.9% 47.7% 54.3% 54.4% 54.8% 54.0% 52.7% 55.3% 53.1% 53.05%
Operating Margin -5.3% -28.1% -10.5% -11.1% -7.2% -7.4% -16.3% -9.5% -11.1% -22.9% 44.5% -16.6% -2.7% -20.4% -19.4% -15.2% -13.9% -7.2% -14.1% -3.1% -3.13%
Net Margin -5.0% -25.3% -9.1% -10.7% -6.7% -7.2% -15.9% -9.9% -11.8% -23.6% 58.3% -36.7% -2.5% -18.9% -19.0% -14.7% -6.1% -7.5% -14.4% -8.0% -7.99%
EBITDA Margin 3.5% -19.8% -1.9% -1.8% 2.5% 1.3% -7.1% 5.2% 3.1% -14.7% -3.9% -0.0% -5.4% 1.4% -2.9% 2.5% -0.5% 2.7% -6.4% -0.5% -0.55%
FCF Margin 3.6% 6.5% 5.5% 2.3% -2.4% -3.6% -8.6% -6.6% -3.5% -1.4% -1.6% -2.3% -7.4% -11.2% -9.1% -10.3% -10.0% -5.0% -4.0% -3.0% -3.04%
OCF Margin 5.8% 8.3% 6.9% 3.7% -1.2% -2.3% -7.2% -5.3% -2.2% 0.0% -0.3% -1.0% -5.3% -9.3% -7.0% -8.1% -8.4% -3.5% -2.6% -1.8% -1.82%
ROE 3Y Avg snapshot only -42.73%
ROE 5Y Avg snapshot only -28.92%
ROA 3Y Avg snapshot only -27.76%
ROIC 3Y Avg snapshot only -45.34%
ROIC Economic snapshot only -12.92%
Cash ROA snapshot only -2.00%
Cash ROIC snapshot only -4.41%
CROIC snapshot only -7.34%
NOPAT Margin snapshot only -7.43%
Pretax Margin snapshot only -9.02%
R&D / Revenue snapshot only 9.01%
SGA / Revenue snapshot only 48.88%
SBC / Revenue snapshot only 3.71%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -4.75 -28.23 -32.00 -26.23 -23.14 -28.96 -26.71 -15.63 -13.13 -7.14 49.79 -18.61 -1.15 -1.38 -1.25 -1.26 -9.17 -12.30 -13.16 -18.53 -15.797
P/S Ratio 2.95 3.06 3.68 3.32 3.01 2.43 2.71 1.56 1.46 1.11 0.96 0.80 0.68 0.84 1.04 0.99 1.34 1.43 1.40 1.67 1.570
P/B Ratio 1.76 2.03 2.49 2.29 2.09 1.81 2.05 1.20 1.15 0.99 0.85 0.69 0.58 1.24 1.48 1.38 1.85 2.28 2.31 2.81 2.860
P/FCF 82.61 47.11 67.54 144.63 -123.75 -66.90 -31.46 -23.55 -41.98 -77.83 -59.32 -35.22 -9.20 -7.52 -11.41 -9.58 -13.46 -28.65 -35.52 -55.03 -55.034
P/OCF 50.95 36.97 53.18 90.54 4803.74
EV/EBITDA -5.47 -93.00 -84.04 -62.59 -54.79 8791.69 -204.80 334.21 221.66 -32.06 -35.75 -20.23 -11.72 -29.97 -46.24 -66.39 560.36 208.37 -318.74 -135.40 -135.400
EV/Revenue 2.90 2.96 3.59 3.22 2.91 2.45 2.73 1.57 1.48 1.17 1.01 0.86 0.74 0.60 0.79 0.74 1.09 1.24 1.22 1.49 1.489
EV/EBIT -4.64 -24.51 -27.35 -22.84 -20.05 -26.44 -25.52 -17.80 -17.18 -9.14 -8.64 -6.61 -4.91 -5.43 -7.07 -6.81 -11.75 -15.05 -14.00 -16.72 -16.717
EV/FCF 81.21 45.62 65.80 140.58 -119.96 -67.33 -31.64 -23.78 -42.41 -81.98 -63.01 -37.90 -10.03 -5.42 -8.73 -7.17 -10.93 -24.82 -30.82 -49.04 -49.042
Earnings Yield -21.0% -3.5% -3.1% -3.8% -4.3% -3.5% -3.7% -6.4% -7.6% -14.0% 2.0% -5.4% -87.1% -72.3% -80.1% -79.2% -10.9% -8.1% -7.6% -5.4% -5.40%
FCF Yield 1.2% 2.1% 1.5% 0.7% -0.8% -1.5% -3.2% -4.2% -2.4% -1.3% -1.7% -2.8% -10.9% -13.3% -8.8% -10.4% -7.4% -3.5% -2.8% -1.8% -1.82%
Price/Tangible Book snapshot only 4.509
EV/Gross Profit snapshot only 2.772
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.97 2.45 2.45 2.45 2.45 1.93 1.93 1.93 1.93 1.95 1.95 1.95 1.95 2.12 2.12 2.12 2.12 2.21 2.21 2.21 2.209
Quick Ratio 1.80 1.60 1.60 1.60 1.60 1.24 1.24 1.24 1.24 1.29 1.29 1.29 1.29 1.46 1.46 1.46 1.46 1.40 1.40 1.40 1.395
Debt/Equity 0.09 0.05 0.05 0.05 0.05 0.08 0.08 0.08 0.08 0.17 0.17 0.17 0.17 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.000
Net Debt/Equity -0.03 -0.06 -0.06 -0.06 -0.06 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.05 -0.35 -0.35 -0.35 -0.35 -0.31 -0.31 -0.31 -0.305
Debt/Assets 0.07 0.04 0.04 0.04 0.04 0.06 0.06 0.06 0.06 0.12 0.12 0.12 0.12 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.000
Debt/EBITDA -0.28 -2.16 -1.57 -1.28 -1.23 383.90 -7.91 21.87 15.16 -5.25 -6.77 -4.62 -3.14 -0.77 -0.94 -1.48 8.60 0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 0.09 3.04 2.22 1.80 1.73 56.34 -1.16 3.21 2.22 -1.62 -2.09 -1.43 -0.97 11.63 14.22 22.31 -129.69 -32.16 48.60 16.54 16.541
Interest Coverage -186.73 -40.87 -48.68 -57.75 -64.65 -42.53 -37.55 -20.38 -14.48 -15.98 -16.99 -26.11 -54.39 -6546.25 -258.19 -258.189
Equity Multiplier 1.31 1.28 1.28 1.28 1.28 1.30 1.30 1.30 1.30 1.41 1.41 1.41 1.41 1.55 1.55 1.55 1.55 1.53 1.53 1.53 1.531
Cash Ratio snapshot only 0.734
Debt Service Coverage snapshot only -31.877
Defensive Interval snapshot only 186.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.38 0.50 0.51 0.52 0.53 0.57 0.58 0.59 0.60 0.62 0.62 0.61 0.60 0.71 0.69 0.67 0.67 0.98 1.01 1.03 1.028
Inventory Turnover 2.56 2.47 2.52 2.61 2.66 3.01 3.06 3.11 3.21 3.08 3.07 3.04 3.03 2.57 2.44 2.34 2.23 2.20 2.25 2.32 2.320
Receivables Turnover 7.28 8.73 8.93 9.10 9.18 7.21 7.31 7.48 7.63 6.44 6.39 6.27 6.16 6.30 6.07 5.94 5.88 6.76 6.95 7.11 7.105
Payables Turnover 6.10 6.93 7.05 7.32 7.46 6.31 6.41 6.52 6.73 4.80 4.79 4.74 4.71 3.82 3.62 3.47 3.31 3.79 3.88 4.00 4.004
DSO 50 42 41 40 40 51 50 49 48 57 57 58 59 58 60 61 62 54 52 51 51.4 days
DIO 143 148 145 140 137 121 119 117 114 118 119 120 121 142 150 156 164 166 162 157 157.3 days
DPO 60 53 52 50 49 58 57 56 54 76 76 77 77 96 101 105 110 96 94 91 91.2 days
Cash Conversion Cycle 133 137 134 130 128 114 112 110 107 99 100 101 102 104 109 112 115 124 121 118 117.6 days
Fixed Asset Turnover snapshot only 9.514
Operating Cycle snapshot only 208.7 days
Cash Velocity snapshot only 5.498
Capital Intensity snapshot only 0.912
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -9.8% 10.2% 11.0% 11.9% 12.3% 8.7% 7.7% 8.1% 9.3% 7.1% 4.7% 0.5% -3.2% -10.3% -12.9% -13.1% -12.6% -3.8% 2.7% 7.3% 7.26%
Net Income -6.2% 81.1% 79.8% 77.6% 76.5% 15.9% 4.9% 14.7% 6.3% -97.5% 1.2% 56.9% -4.2% -2.5% -38.7% -14.9% 78.5% 81.6% 86.8% 87.7% 87.67%
EPS -6.2% 81.3% 80.1% 78.0% 76.9% 17.2% 6.3% 15.6% 7.3% -95.3% 1.2% 57.6% -4.1% -2.4% -38.1% -14.6% 78.8% 81.8% 87.0% 87.8% 87.81%
FCF 29.4% 1.9% 1.8% 1.5% -1.8% -1.6% -2.7% -4.1% -56.7% 58.1% 80.4% 65.7% -1.1% -6.0% -3.9% -3.0% -17.4% 57.0% 55.3% 68.5% 68.50%
EBITDA -48.7% 93.5% 91.3% 89.4% 88.7% 1.0% 66.4% 1.1% 1.1% -140.9% -1.2% -10.0% -10.2% 50.2% 47.4% 77.1% 1.0% 1.3% 77.1% -5.7% -5.69%
Op. Income -5.3% 78.9% 77.7% 75.6% 74.4% 19.3% 12.0% 21.4% 15.8% -79.8% 91.5% 76.3% -4.4% -2.8% -83.4% -29.4% 75.5% 79.2% 84.4% 87.9% 87.88%
OCF Growth snapshot only 75.97%
Asset Growth snapshot only -11.81%
Equity Growth snapshot only -11.00%
Debt Growth snapshot only -1.00%
Shares Change snapshot only 1.18%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -7.4% -5.4% -4.7% -4.6% -4.5% -4.2% -1.9% 1.0% 3.5% 8.6% 7.8% 6.7% 5.9% 1.5% -0.6% -1.9% -2.5% -2.6% -2.1% -2.1% -2.14%
Revenue 5Y -4.9% -3.8% -3.6% -3.3% -3.0% -2.0% -1.6% -1.0% -0.5% -0.3% -0.5% -1.1% -1.6% -3.3% -3.0% -2.1% -1.3% 2.1% 2.3% 2.5% 2.54%
EPS 3Y
EPS 5Y -17.7%
Net Income 3Y
Net Income 5Y -16.5%
EBITDA 3Y 1.7%
EBITDA 5Y -70.2% -39.8% -34.7%
Gross Profit 3Y -5.6% -3.9% -2.1% -1.6% -0.1% 8.3% 8.2% 8.9% 8.7% 5.1% 5.2% 4.5% 4.0% -0.4% -2.1% -2.2% -1.6% -1.6% -1.0% -1.4% -1.44%
Gross Profit 5Y -4.1% -2.1% -1.8% -1.6% -1.7% -1.2% -0.5% 0.3% 0.3% -0.3% 0.0% -0.3% 0.1% 3.5% 2.7% 2.5% 2.5% 1.0% 2.0% 2.4% 2.42%
Op. Income 3Y
Op. Income 5Y
FCF 3Y -33.3% -20.5% -14.0% -37.4%
FCF 5Y -22.3% -13.8% -17.6% -31.8%
OCF 3Y -24.4% -16.4% -11.1% -29.8%
OCF 5Y -15.9% -11.8% -15.5% -26.9% -71.5%
Assets 3Y -5.6% -7.3% -7.3% -7.3% -7.3% -12.9% -12.9% -12.9% -12.9% -3.7% -3.7% -3.7% -3.7% -17.3% -17.3% -17.3% -17.3% -20.3% -20.3% -20.3% -20.27%
Assets 5Y -5.1% -5.1% -5.1% -5.1% -5.1% -4.8% -4.8% -4.8% -4.8% -5.5% -5.5% -5.5% -5.5% -17.6% -17.6% -17.6% -17.6% -14.0% -14.0% -14.0% -14.00%
Equity 3Y -4.1% -6.8% -6.8% -6.8% -6.8% -11.6% -11.6% -11.6% -11.6% -6.0% -6.0% -6.0% -6.0% -22.4% -22.4% -22.4% -22.4% -24.5% -24.5% -24.5% -24.46%
Book Value 3Y -4.9% -7.4% -7.9% -7.5% -8.1% -12.3% -12.8% -12.7% -12.8% -7.3% -7.5% -7.5% -7.5% -23.6% -23.6% -23.6% -23.5% -25.6% -25.6% -25.6% -25.64%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.69 0.52 0.66 0.69 0.63 0.30 0.26 0.14 0.04 0.00 0.00 0.00 0.01 0.23 0.23 0.10 0.01 0.15 0.13 0.11 0.107
Earnings Stability 0.44 0.15 0.16 0.21 0.26 0.13 0.15 0.12 0.15 0.05 0.00 0.00 0.34 0.13 0.11 0.11 0.01 0.02 0.00 0.01 0.011
Margin Stability 0.93 0.84 0.87 0.90 0.92 0.84 0.87 0.90 0.93 0.96 0.96 0.96 0.94 0.85 0.88 0.91 0.93 0.95 0.97 0.98 0.976
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.94 0.98 0.94 0.97 0.50 0.20 0.50 0.50 0.50 0.20 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend -0.36 0.12 0.12 0.11 0.11 0.16 0.15 0.15 0.14 -0.07 0.09 0.04 -0.42 -0.80 -1.15 -1.04 0.10 0.33 0.41 0.41 0.414
Gross Margin Trend 0.08 0.07 0.07 0.05 0.04 -0.03 -0.02 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 -0.01 -0.00 0.01 0.03 0.03 0.03 0.02 0.020
FCF Margin Trend -0.01 0.06 0.04 0.01 -0.04 -0.03 -0.07 -0.05 -0.04 -0.03 -0.00 -0.00 -0.04 -0.09 -0.04 -0.06 -0.05 0.01 0.01 0.03 0.033
Sustainable Growth Rate 1.6%
Internal Growth Rate 1.2%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.09 -0.76 -0.60 -0.29 0.09 0.27 0.71 0.53 0.20 -0.00 -0.17 0.23 0.09 0.15 0.08 0.10 0.58 0.30 0.24 0.20 0.202
FCF/OCF 0.62 0.78 0.79 0.63 2.09 1.60 1.20 1.24 1.59 -61.72 5.03 2.25 1.40 1.20 1.30 1.27 1.18 1.44 1.53 1.67 1.666
FCF/Net Income snapshot only 0.337
CapEx/Revenue 2.2% 1.8% 1.5% 1.4% 1.3% 1.4% 1.4% 1.3% 1.3% 1.4% 1.3% 1.3% 2.1% 1.9% 2.1% 2.2% 1.5% 1.5% 1.4% 1.2% 1.21%
CapEx/Depreciation snapshot only 0.155
Accruals Ratio -0.26 -0.10 -0.09 -0.09 -0.06 -0.03 -0.02 -0.03 -0.05 -0.10 0.01 -0.02 -0.32 -0.37 -0.52 -0.47 -0.04 -0.08 -0.08 -0.07 -0.074
Sloan Accruals snapshot only -0.114
Cash Flow Adequacy snapshot only -1.502
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.6% 0.4% 0.4% 0.3% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.6% 0.2% 0.2% -0.0% -0.2% -0.22%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.6% 0.2% 0.2% -0.0% -0.2% -0.22%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.99 0.88 0.86 0.88 0.88 0.89 0.93 0.92 0.95 0.96 -1.13 1.52 0.96 0.96 1.02 0.95 0.98 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.01 1.02 1.02 1.02 1.02 1.02 1.03 1.22 1.37 1.26 0.15 0.22 4.07 5.66 7.29 7.61 1.60 1.41 1.23 1.01 1.013
EBIT Margin -0.62 -0.12 -0.13 -0.14 -0.15 -0.09 -0.11 -0.09 -0.09 -0.13 -0.12 -0.13 -0.15 -0.11 -0.11 -0.11 -0.09 -0.08 -0.09 -0.09 -0.089
Asset Turnover 0.38 0.50 0.51 0.52 0.53 0.57 0.58 0.59 0.60 0.62 0.62 0.61 0.60 0.71 0.69 0.67 0.67 0.98 1.01 1.03 1.028
Equity Multiplier 1.34 1.29 1.29 1.29 1.29 1.29 1.29 1.29 1.29 1.35 1.35 1.35 1.35 1.46 1.46 1.46 1.46 1.54 1.54 1.54 1.539
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-4.41 $-0.82 $-0.88 $-0.98 $-1.02 $-0.68 $-0.83 $-0.83 $-0.94 $-1.32 $0.16 $-0.35 $-4.78 $-4.56 $-5.98 $-5.49 $-1.01 $-0.83 $-0.78 $-0.67 $-0.67
Book Value/Share $11.88 $11.41 $11.35 $11.25 $11.24 $10.84 $10.80 $10.75 $10.74 $9.55 $9.46 $9.41 $9.40 $5.09 $5.06 $5.02 $5.03 $4.46 $4.44 $4.42 $4.17
Tangible Book/Share $1.49 $1.80 $1.79 $1.77 $1.77 $1.81 $1.81 $1.80 $1.80 $2.72 $2.70 $2.68 $2.68 $3.17 $3.15 $3.13 $3.14 $2.78 $2.77 $2.75 $2.75
Revenue/Share $7.10 $7.55 $7.69 $7.77 $7.83 $8.08 $8.16 $8.30 $8.47 $8.55 $8.40 $8.19 $8.05 $7.52 $7.20 $7.00 $6.94 $7.14 $7.30 $7.42 $7.54
FCF/Share $0.25 $0.49 $0.42 $0.18 $-0.19 $-0.29 $-0.70 $-0.55 $-0.29 $-0.12 $-0.14 $-0.19 $-0.60 $-0.84 $-0.65 $-0.72 $-0.69 $-0.36 $-0.29 $-0.23 $0.04
OCF/Share $0.41 $0.63 $0.53 $0.28 $-0.09 $-0.18 $-0.59 $-0.44 $-0.19 $0.00 $-0.03 $-0.08 $-0.43 $-0.70 $-0.50 $-0.57 $-0.59 $-0.25 $-0.19 $-0.14 $0.11
Cash/Share $1.42 $1.25 $1.24 $1.23 $1.23 $0.74 $0.73 $0.73 $0.73 $1.13 $1.12 $1.11 $1.11 $1.88 $1.87 $1.86 $1.86 $1.36 $1.36 $1.35 $0.91
EBITDA/Share $-3.77 $-0.24 $-0.33 $-0.40 $-0.42 $0.00 $-0.11 $0.04 $0.06 $-0.31 $-0.24 $-0.35 $-0.51 $-0.15 $-0.12 $-0.08 $0.01 $0.04 $-0.03 $-0.08 $-0.08
Debt/Share $1.06 $0.52 $0.52 $0.51 $0.51 $0.86 $0.86 $0.86 $0.86 $1.63 $1.62 $1.61 $1.61 $0.12 $0.12 $0.12 $0.12 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-0.35 $-0.73 $-0.73 $-0.72 $-0.72 $0.13 $0.13 $0.13 $0.13 $0.50 $0.50 $0.50 $0.50 $-1.76 $-1.75 $-1.74 $-1.75 $-1.36 $-1.36 $-1.35 $-1.35
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 2.194
Altman Z-Prime snapshot only 2.054
Piotroski F-Score 3 5 5 4 3 3 3 4 3 4 4 4 2 4 4 4 5 4 5 4 4
Beneish M-Score -4.14 -2.87 -2.92 -2.81 -2.70 -2.22 -2.14 -2.20 -2.31 -3.00 -2.52 -2.66 -4.11 -5.29 -6.28 -5.99 -3.29 -2.99 -3.03 -2.97 -2.971
Ohlson O-Score snapshot only -7.363
ROIC (Greenblatt) snapshot only -22.00%
Net-Net WC snapshot only $1.72
EVA snapshot only $-35545020.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 50.62 65.20 65.78 64.70 56.04 43.64 55.14 38.09 33.16 37.00 36.13 31.46 32.11 43.24 43.07 42.52 38.56 66.20 41.11 47.44 47.441
Credit Grade snapshot only 11
Credit Trend snapshot only 4.925
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 32
Sector Credit Rank snapshot only 45

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms